Clinical trials
Withdrawn Phase 1 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Dana-Farber Cancer Institute | 1 |
| Duke University | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Northwestern University | 1 |
| OHSU Knight Cancer Institute | 1 |
| QuantumLeap Healthcare Collaborative | 1 |
| Rush University Medical Center | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 15 |
| Breast Neoplasms | 7 |
| Ovarian Neoplasms | 4 |
| Fallopian Tube Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Endometrial Neoplasms | 1 |
| Inflammatory Breast Neoplasms | 1 |
| Influenza, Human | 1 |
| Mesothelioma | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.